Serum IL-13 Concentration Response to Surgical Treatment in Patients with Laryngeal Squamous Cell Carcinoma

Wynn T.A. IL-13 effector functions. Annu Rev Immunol 2003; 21: 425–56.

Puri R.K. Structure and function of interleukin-4 and its receptor. In: Kurzrock R. , Talpaz M. , eds. Cytokines: interleukins and their receptors. Boston: Kluwer 1995; 143–85.

Mehrotra R. Interleukin 13 is secreted by human head and neck tumours and does not modulate their growth in vitro. Indian J Exp Biol 1998; 36: 805–7.

Kawakami K. , Kawakami M. , Joshi B.H. , Puri R.K. Interleukin-13 receptor targeted cancer therapy in an immunodeficient animal model of human head and neck cancer. Cancer Res 2001; 61: 6194–200.

Kawakami M. , Kawakami K. , Puri R.K. Apoptotic pathways of cell death induced by an interleukin-13 receptor targeted recombinant cytotoxin in head and neck cancer cells. Cancer Immunol Immunother 2001; 50: 691–700.

Denizot Y. , Turlure P. , Bordessoule D. , Trimoreau F. , Praloran V. Serum IL-10 and IL-13 concentrations in patients with haematological malignancies. Cytokine 1999; 11: 634–5.

Kanai T. , Watanabe M. , Hayashi A. . Regulatory effect of interleukin-4 and interleukin-13 on colon cancer cell adhesion. Br J Cancer 2000; 82: 1717–23.

Kobayashi M. , Kobayashi H. , Pollard R.B. , Suzuki F. A pathogenetic role of Th2 cells and their cytokine products on the pulmonary metastasis of murine B16 melanoma. J Immunol 1998; 160: 5869–73.

Terabe M. , Matsui S. , Noben-Trauth N. , Chen H. , Watson C. NKT cell-mediated repression of tumor immunosurveillance by IL-13 and the IL-4R-STAT6 pathway. Nat Immunol 2000; 1: 515–20.

Pignataro L. , Corsi M.M. , Sambataro G. , Porcaro L. , Tredici P. , Broich G. Plasmatic cytokine network in patients with laryngeal carcinoma after surgical treatment. Anticancer Res 2001; 21: 3621–5.